Chairman and CEO of Emmaus Life Sciences Inc (30-Year Financial, Insider Trades) Yutaka Niihara (insider trades) bought 31,700 shares of EMMA on 08/27/2019 at an average price of $2.76 a share. The total cost of this purchase was $87,492.
MYnd Analytics Inc is a cloud-based predictive analytics company. It provides clinical decision support to mental healthcare providers for the treatment of behavioral disorders, including depression, bipolar disorder and post-traumatic stress disorder. Emmaus Life Sciences Inc has a market cap of $125.450 million; its shares were traded at around $2.64 with and P/S ratio of 2.09. Emmaus Life Sciences Inc had annual average EBITDA growth of 51.70% over the past ten years. GuruFocus has detected 2 severe warning signs with Emmaus Life Sciences Inc. .
CEO Recent Trades:
- Chairman and CEO, 10% Owner Yutaka Niihara bought 8,300 shares of EMMA stock on 08/27/2019 at the average price of $2.64. The price of the stock has decreased by 0% since.
- Chairman and CEO, 10% Owner Yutaka Niihara bought 31,700 shares of EMMA stock on 08/27/2019 at the average price of $2.76. The price of the stock has decreased by 4.35% since.
- Chairman and CEO, 10% Owner Yutaka Niihara bought 19,500 shares of EMMA stock on 08/21/2019 at the average price of $3.38. The price of the stock has decreased by 21.89% since.
Directors and Officers Recent Trades:
- Vice Chairman & COO Willis C Lee bought 1,000 shares of EMMA stock on 08/21/2019 at the average price of $3.35. The price of the stock has decreased by 21.19% since.
For the complete insider trading history of EMMA, click here
.
